Stay updated on Pembrolizumab Combo in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Ovarian Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of showing the study record content, indicating a permissions issue on the page.
    Difference
    20%
    Check dated 2026-09-23T01:04:15.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page revision identifier was updated from v3.6.6 to v3.7.0, indicating a refresh of the page content or layout without changing the underlying study information.
    Difference
    0.1%
    Check dated 2026-09-16T00:13:57.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.6.6, replacing the previous Revision: v3.6.5, indicating a new build release.
    Difference
    0.1%
    Check dated 2026-09-01T19:39:22.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    A citation for the Maveropepimut-S, pembrolizumab and low-dose cyclophosphamide paper was added to the Publications section, replacing the previous 'Online ahead of print' entry with the finalized Nat Commun article details (authors, title, journal, date, volume, and DOI).
    Difference
    0.1%
    Check dated 2026-08-18T19:52:19.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.4 to v3.6.5, indicating a new page release. This update reflects backend/frontend maintenance and does not modify study details or how the page is used by visitors.
    Difference
    0.1%
    Check dated 2026-08-11T18:38:27.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The page footer shows Revision: v3.6.4, replacing the previous Revision: v3.6.3, indicating a minor interface update.
    Difference
    0.1%
    Check dated 2026-07-28T12:30:47.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Ovarian Cancer Clinical Trial page.